BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26494409)

  • 1. Dropped-head in recessive oculopharyngeal muscular dystrophy.
    Garibaldi M; Pennisi EM; Bruttini M; Bizzarri V; Bucci E; Morino S; Talerico C; Stoppacciaro A; Renieri A; Antonini G
    Neuromuscul Disord; 2015 Nov; 25(11):869-72. PubMed ID: 26494409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Japanese case of oculopharyngeal muscular dystrophy (OPMD) with PABPN1 c.35G > C; p.Gly12Ala point mutation.
    Nishii YS; Noto YI; Yasuda R; Kitaoji T; Ashida S; Tanaka E; Minami N; Nishino I; Mizuno T
    BMC Neurol; 2021 Jul; 21(1):265. PubMed ID: 34225694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oculopharyngeal muscular dystrophy: phenotypic and genotypic characteristics of 9 Polish patients.
    Nadaj-Pakleza A; Richard P; Lusakowska A; Gajewska J; Jamrozik Z; Kostera-Pruszczyk A; Kwieciński H; Kamińska A
    Neurol Neurochir Pol; 2009; 43(2):113-20. PubMed ID: 19484687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Siblings with recessive oculopharyngeal muscular dystrophy.
    Hebbar S; Webberley MJ; Lunt P; Robinson DO
    Neuromuscul Disord; 2007 Mar; 17(3):254-7. PubMed ID: 17296297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranuclear Aggregates Precede Clinical Onset in Oculopharyngeal Muscular Dystrophy.
    van der Sluijs BM; Raz V; Lammens M; van den Heuvel LP; Voermans NC; van Engelen BG
    J Neuromuscul Dis; 2016 Mar; 3(1):101-109. PubMed ID: 27854203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myopathy phenotype in transgenic mice expressing mutated PABPN1 as a model of oculopharyngeal muscular dystrophy.
    Hino H; Araki K; Uyama E; Takeya M; Araki M; Yoshinobu K; Miike K; Kawazoe Y; Maeda Y; Uchino M; Yamamura K
    Hum Mol Genet; 2004 Jan; 13(2):181-90. PubMed ID: 14645203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability of the recessive oculopharyngeal muscular dystrophy phenotype.
    Semmler A; Kress W; Vielhaber S; Schröder R; Kornblum C
    Muscle Nerve; 2007 May; 35(5):681-4. PubMed ID: 17206657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A de novo PABPN1 germline mutation in a patient with oculopharyngeal muscular dystrophy.
    Gürtler N; Plasilova M; Podvinec M; Boesch N; Müller H; Heinimann K
    Laryngoscope; 2006 Jan; 116(1):111-4. PubMed ID: 16481821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The phenotypic and genotypic features of Chinese patients with oculopharyngeal muscular dystrophy.
    Lin F; Yang K; Lin MT; Zheng FZ; Chen L; Ding YL; Ye ZX; Lin X; Wang N; Wang ZQ
    Ann Clin Transl Neurol; 2023 Mar; 10(3):426-439. PubMed ID: 36691350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Case of Oculopharyngeal Muscular Dystrophy Caused by a Novel PABPN1 c.34G > T (p.Gly12Trp) Point Mutation without Polyalanine Expansion.
    Takahashi Y; Morimoto N; Nada T; Morimoto M; Eura N; Minami N; Nishino I
    J Neuromuscul Dis; 2023; 10(3):459-463. PubMed ID: 36847015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between PABPN1 genotype and disease severity in oculopharyngeal muscular dystrophy.
    Richard P; Trollet C; Stojkovic T; de Becdelievre A; Perie S; Pouget J; Eymard B;
    Neurology; 2017 Jan; 88(4):359-365. PubMed ID: 28011929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and genetic features of a large homogeneous cohort of oculopharyngeal muscular dystrophy patients from the Canary Islands.
    Alonso-Pérez J; de León Hernández JC; Pérez-Pérez H; Mendoza-Grimón MD; Gutierrez-Martinez AJ; Hadjigeorgiou I; Montón-Álvarez F; González-Quereda L; Alonso-Jimenez A; Suárez-Calvet X; Díaz-Manera J
    Eur J Neurol; 2022 May; 29(5):1488-1495. PubMed ID: 35112761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oculopharyngeal muscular dystrophy with PABPN1 mutation in a Chinese Malaysian woman.
    Goh KJ; Wong KT; Nishino I; Minami N; Nonaka I
    Neuromuscul Disord; 2005 Mar; 15(3):262-4. PubMed ID: 15725589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel mouse models of oculopharyngeal muscular dystrophy (OPMD) reveal early onset mitochondrial defects and suggest loss of PABPN1 may contribute to pathology.
    Vest KE; Phillips BL; Banerjee A; Apponi LH; Dammer EB; Xu W; Zheng D; Yu J; Tian B; Pavlath GK; Corbett AH
    Hum Mol Genet; 2017 Sep; 26(17):3235-3252. PubMed ID: 28575395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Drosophila model of oculopharyngeal muscular dystrophy reveals intrinsic toxicity of PABPN1.
    Chartier A; Benoit B; Simonelig M
    EMBO J; 2006 May; 25(10):2253-62. PubMed ID: 16642034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of PABPN1 nuclear inclusions on a large cohort of patients and in a human xenograft model of oculopharyngeal muscular dystrophy.
    Roth F; Dhiab J; Boulinguiez A; Mouigni HR; Lassche S; Negroni E; Muraine L; Marhic A; Oliver A; Lainé J; Rouche A; O'Ferrall EK; van Engelen B; Ottenheijm C; Greif H; Blumen S; Lacau St Guily J; Perie S; Butler-Browne G; Mouly V; Trollet C
    Acta Neuropathol; 2022 Dec; 144(6):1157-1170. PubMed ID: 36197469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of insoluble PABPN1 accumulation in the diagnosis of oculopharyngeal muscular dystrophy.
    Galimberti V; Tironi R; Lerario A; Scali M; Del Bo R; Rodolico C; Brizzi T; Gibertini S; Maggi L; Mora M; Toscano A; Comi GP; Sciacco M; Moggio M; Peverelli L
    Eur J Neurol; 2020 Apr; 27(4):709-715. PubMed ID: 31769567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and phenotypic characterization of a mouse model of oculopharyngeal muscular dystrophy reveals severe muscular atrophy restricted to fast glycolytic fibres.
    Trollet C; Anvar SY; Venema A; Hargreaves IP; Foster K; Vignaud A; Ferry A; Negroni E; Hourde C; Baraibar MA; 't Hoen PA; Davies JE; Rubinsztein DC; Heales SJ; Mouly V; van der Maarel SM; Butler-Browne G; Raz V; Dickson G
    Hum Mol Genet; 2010 Jun; 19(11):2191-207. PubMed ID: 20207626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial localization of PABPN1 in oculopharyngeal muscular dystrophy.
    Doki T; Yamashita S; Wei FY; Hara K; Yamamoto T; Zhang Z; Zhang X; Tawara N; Hino H; Uyama E; Kurashige T; Maruyama H; Tomizawa K; Ando Y
    Lab Invest; 2019 Nov; 99(11):1728-1740. PubMed ID: 30894671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oculopharyngeal muscular dystrophy --an under-diagnosed disease in China? Report a China-born Chinese with PABPN1 mutation and epidemiology review of the literature.
    Chien YY
    J Formos Med Assoc; 2012 Jul; 111(7):397-402. PubMed ID: 22817818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.